Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 5, 2014, Pages 518-523

  Baragetti, A ^a,b   Knoflach, M ^c   Cuccovillo, I ^d   Grigore, L ^a   Casula, M ^b   Garlaschelli, K ^a   Mantovani, A ^b,d   Wick, G ^e   Kiechl, S ^c   Willeit, J ^c   Bottazzi, B ^d   Catapano, A L ^b,f   Norata, G D ^a,b,g  

^a Bassini Hospital   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e Laboratory of Autoimmunity   (Austria)

^f IRCCS MULTIMEDICA   (Italy)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bruneck study; Inflammation; PLIC study; PTX3

Indexed keywords

PENTRAXIN 3; BIOLOGICAL MARKER; C REACTIVE PROTEIN; SERUM AMYLOID P;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; MALE; OBSERVER VARIATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ANIMAL; BLOOD; CARDIOVASCULAR DISEASE; COMMON CAROTID ARTERY; ECHOGRAPHY; FOLLOW UP; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SERUM AMYLOID P-COMPONENT;

EID: 84899088364     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.10.030     Document Type: Article

References (20)

1. Bottazzi B., Doni A., Garlanda C., Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 2010, 28:157-183.
2. Peri G., Introna M., Corradi D., Iacuitti G., Signorini S., Avanzini F., et al. PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000, 102:636-641.
3. Bonacina F., Baragetti A., Catapano A.L., Norata G.D. Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases. Mediators Inflamm 2013, 2013:10.
4. Latini R., Maggioni A.P., Peri G., Gonzini L., Lucci D., Mocarelli P., et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004, 110:2349-2354.
5. Norata G.D., Garlanda C., Catapano A.L. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med 2010, 20:35-40.
6. Poli A., Tremoli E., Colombo A., Sirtori M., Pignoli P., Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988, 70:253-261.
7. Knoflach M., Kiechl S., Mantovani A., Cuccovillo I., Bottazzi B., Xu Q., et al. Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY studies. PLoS One 2012, 7:e31474.
8. Zanetti M., Bosutti A., Ferreira C., Vinci P., Biolo G., Fonda M., et al. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. Clin Exp Med 2009, 9:243-248.
9. Norata G.D., Marchesi P., Pirillo A., Uboldi P., Chiesa G., Maina V., et al. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 2008, 28:925-931.
10. Norata G.D., Pirillo A., Ammirati E., Catapano A.L. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 2012, 220:11-21.
11. Norata G.D., Garlaschelli K., Grigore L., Tibolla G., Raselli S., Redaelli L., et al. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis 2009, 19:129-134.
12. Norata G.D., Raselli S., Grigore L., Garlaschelli K., Vianello D., Bertocco S., et al. Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells. Atherosclerosis 2009, 206:556-562.
13. Lorenz M.W., Polak J.F., Kavousi M., Mathiesen E.B., Volzke H., Tuomainen T.P., et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 2012, 379:2053-2062.
14. Baldassarre D., Veglia F., Hamsten A., Humphries S.E., Rauramaa R., de Faire U., et al. Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study. Arterioscler Thromb Vasc Biol 2013, 33:2273-2279.
15. Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008, 21:93-111. quiz 89-90.
16. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
17. Salio M., Chimenti S., De Angelis N., Molla F., Maina V., Nebuloni M., et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2008, 117:1055-1064.
18. Pasqualini F., Anselmo A., Moalli F., et al. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 2009, 120:699-708.
19. Frémaux I., Doni A., Moalli F., et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007, 204:793-804.
20. Maugeri N., Rovere-Querini P., Slavich M., Coppi G., Doni A., Bottazzi B., et al. Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. J Immunol 2011, 187:970-979.